Literature DB >> 32362246

The A-to-I RNA Editing Enzyme Adar1 Is Essential for Normal Embryonic Cardiac Growth and Development.

Joseph B Moore1, Ghazal Sadri1, Annalara G Fischer1, Tyler Weirick2, Giuseppe Militello2, Marcin Wysoczynski1, Anna M Gumpert3, Thomas Braun4, Shizuka Uchida1,2.   

Abstract

Entities:  

Keywords:  RNA editing; cell death; high-throughput nucleotide sequencing; myocardium; myocytes, cardiac

Mesh：

Substances：

Year:  2020        PMID： 32362246      PMCID： PMC7415551          DOI： 10.1161/CIRCRESAHA.120.316932

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  4 in total

Review 1.  RNA Editing: Unexplored Opportunities in the Cardiovascular System.

Authors:  Shizuka Uchida; Steven P Jones
Journal:  Circ Res       Date:  2018-02-02       Impact factor: 17.367

2.  ADAR-related activation of adenosine-to-inosine RNA editing during regeneration.

Authors:  Nevin M Witman; Mikaela Behm; Marie Ohman; Jamie I Morrison
Journal:  Stem Cells Dev       Date:  2013-05-03       Impact factor: 3.272

3.  Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene.

Authors:  Qingde Wang; Mana Miyakoda; Weidong Yang; Jaspal Khillan; David L Stachura; Mitchell J Weiss; Kazuko Nishikura
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

4.  Cardiomyocyte Specific Deletion of ADAR1 Causes Severe Cardiac Dysfunction and Increased Lethality.

Authors:  Hamid El Azzouzi; Andreia P Vilaça; Dries A M Feyen; Willemijn M Gommans; Roel A de Weger; Pieter A F Doevendans; Joost P G Sluijter
Journal:  Front Cardiovasc Med       Date:  2020-03-18
  4 in total
  8 in total

Review 1.  A-to-I RNA Editing in Cancer: From Evaluating the Editing Level to Exploring the Editing Effects.

Authors:  Heming Wang; Sinuo Chen; Jiayi Wei; Guangqi Song; Yicheng Zhao
Journal:  Front Oncol       Date:  2021-02-11       Impact factor: 6.244

2.  ADAR1 RNA editing regulates endothelial cell functions via the MDA-5 RNA sensing signaling pathway.

Authors:  Xinfeng Guo; Silvia Liu; Rose Yan; Vy Nguyen; Mazen Zenati; Timothy R Billiar; Qingde Wang
Journal:  Life Sci Alliance       Date:  2021-12-30

Review 3.  Epitranscriptomics of cardiovascular diseases (Review).

Authors:  Stefanos Leptidis; Eleni Papakonstantinou; Kalliopi Io Diakou; Katerina Pierouli; Thanasis Mitsis; Konstantina Dragoumani; Flora Bacopoulou; Despina Sanoudou; George P Chrousos; Dimitrios Vlachakis
Journal:  Int J Mol Med       Date:  2021-11-18       Impact factor: 4.101

Review 4.  Functional roles of epitranscriptomic marks in the cardiovascular system and disease: a narrative review.

Authors:  Mirolyuba Ilieva; Shizuka Uchida
Journal:  Ann Transl Med       Date:  2022-07

Review 5.  Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases.

Authors:  Vilbert Sikorski; Antti Vento; Esko Kankuri
Journal:  Mol Ther Nucleic Acids       Date:  2022-07-20       Impact factor: 10.183

Review 6.  Change of Heart: the Epitranscriptome of Small Non-coding RNAs in Heart Failure.

Authors:  Tamar Woudenberg; Nyika D Kruyt; Paul H A Quax; A Yaël Nossent
Journal:  Curr Heart Fail Rep       Date:  2022-07-25

7.  RNA Editing Therapeutics: Advances, Challenges and Perspectives on Combating Heart Disease.

Authors:  Maria Birgaoanu; Marco Sachse; Aikaterini Gatsiou
Journal:  Cardiovasc Drugs Ther       Date:  2022-10-14       Impact factor: 3.947

8.  ADAR2 increases in exercised heart and protects against myocardial infarction and doxorubicin-induced cardiotoxicity.

Authors:  Xiaoting Wu; Lijun Wang; Kai Wang; Jin Li; Rui Chen; Xiaodong Wu; Gehui Ni; Chang Liu; Saumya Das; Joost P G Sluijter; Xinli Li; Junjie Xiao
Journal:  Mol Ther       Date:  2021-07-16       Impact factor: 11.454
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.